Skip to main content
Top
Published in: Child's Nervous System 8/2013

01-08-2013 | Original Paper

Can we safely administer the recommended dose of phenobarbital in very low birth weight infants?

Authors: Osman Oztekin, Salih Kalay, Gonul Tezel, Mustafa Akcakus, Nihal Oygur

Published in: Child's Nervous System | Issue 8/2013

Login to get access

Abstract

Aim

We investigated whether the recommended phenobarbital loading dose of 15–20 mg/kg with maintenance of 3–4 mg/kg/day can safely be administered to very low birth weight preterm newborns with seizures.

Methods

Twenty-four convulsive preterms of <1,500 g were enrolled in the study. Phenobarbital was administered intravenously with a loading dose of 15 mg/kg in approximately 10–15 min. After 24 h, the maintenance dose of 3 mg/kg/day was administered as a single injection. Blood samples were obtained 2, 24, 48, 72, and 96 h after the phenobarbital loading dose was administered, immediately before the next phenobarbital dose was injected.

Results

None of the cases had plasma phenobarbital concentrations above the therapeutic upper limit of 40 μg/mL on the 2nd hour; one case (4.7 %), on the 24th; 11 cases (45.8 %), on the 48th; 15 cases (62.5 %), on the 72nd; and 17 cases (70.8 %), on the 96th hour. A negative correlation was detected between the serum concentrations of phenobarbital and gestational age on the 72th (p, 0.036; r, −0.608) and 96th hour (p, 0.043; r, −0.769).

Conclusions

We suggest that particular attention should be done while administering phenobarbital in preterms, as blood levels of phenobarbital are higher than the reference ranges that those are often reached with the recommended doses in these groups of babies.
Literature
1.
go back to reference Blume HK, Garrison MM, Christakis DA (2009) Neonatal seizures: treatment and treatment variability in 31 United States Pediatric Hospitals. J Child Neurol 24:148–154PubMedCrossRef Blume HK, Garrison MM, Christakis DA (2009) Neonatal seizures: treatment and treatment variability in 31 United States Pediatric Hospitals. J Child Neurol 24:148–154PubMedCrossRef
2.
go back to reference Bartha AI, Shen J, Katz KH, Mischel RE, Yap KR, Ivacko JA, Andrews EM, Ferriero DM, Ment LR, Silverstein FS (2007) Neonatal seizures: multicenter variability in current treatment practices. Pediatr Neurol 37:85–90PubMedCrossRef Bartha AI, Shen J, Katz KH, Mischel RE, Yap KR, Ivacko JA, Andrews EM, Ferriero DM, Ment LR, Silverstein FS (2007) Neonatal seizures: multicenter variability in current treatment practices. Pediatr Neurol 37:85–90PubMedCrossRef
3.
go back to reference Scher MS (2011) Seizures in neonates. In: Martin RJ, Fanaroff AA, Walsh CH, Walsh MC (eds) Fanaroff and Martin's neonatal-perinatal medicine, 9th edn. Elsevier Mosby, Missouri, pp 976–997 Scher MS (2011) Seizures in neonates. In: Martin RJ, Fanaroff AA, Walsh CH, Walsh MC (eds) Fanaroff and Martin's neonatal-perinatal medicine, 9th edn. Elsevier Mosby, Missouri, pp 976–997
4.
go back to reference Scher MS (2005) Neonatal seizures. In: Taeusch HW, Ballard RA, Gleason CA (eds) Avery's disease of the newborn, 8th edn. Elsevier Saunders 1020, Philadelphia Scher MS (2005) Neonatal seizures. In: Taeusch HW, Ballard RA, Gleason CA (eds) Avery's disease of the newborn, 8th edn. Elsevier Saunders 1020, Philadelphia
5.
go back to reference Volpe JJ (2008) Neurology of the newborn, 5th edn. Saunders Elsevier, Philadelphia, pp 231–232 Volpe JJ (2008) Neurology of the newborn, 5th edn. Saunders Elsevier, Philadelphia, pp 231–232
6.
go back to reference Sharpe S, Haas RH (2009) Levetiracetam in the treatment of neonatal seizures. J Pediatr Neurol 7:79–83 Sharpe S, Haas RH (2009) Levetiracetam in the treatment of neonatal seizures. J Pediatr Neurol 7:79–83
7.
go back to reference Ramantani G, Ikonomidou C, Walter B, Rating D, Dinger J (2010) Levetiracetam: safety and efficacy in neonatal seizures. Eur J Pediatr Neurol 3:1–7 Ramantani G, Ikonomidou C, Walter B, Rating D, Dinger J (2010) Levetiracetam: safety and efficacy in neonatal seizures. Eur J Pediatr Neurol 3:1–7
8.
go back to reference Fürwentsches A, Bussman C, Ramantani G (2010) Levetiracetam in the treatment of neonatal seizures: a pilot study. Seizure 19:185–189PubMedCrossRef Fürwentsches A, Bussman C, Ramantani G (2010) Levetiracetam in the treatment of neonatal seizures: a pilot study. Seizure 19:185–189PubMedCrossRef
9.
go back to reference Glass HC, Poulin C, Shevel MI (2011) Topiramate for the treatment of neonatal seizures. Pediatr Neurol 44:439–442PubMedCrossRef Glass HC, Poulin C, Shevel MI (2011) Topiramate for the treatment of neonatal seizures. Pediatr Neurol 44:439–442PubMedCrossRef
10.
go back to reference Sharpe CM, Capparelli EV, Mower A, Farrell MJ, Soldin SJ, Haas RH (2012) A seven-day study of the pharmacokinetics of intravenous levetiracetam in neonates: marked changes in pharmacokinetics occur during the first week of life. Pediatr Research 72:43–49CrossRef Sharpe CM, Capparelli EV, Mower A, Farrell MJ, Soldin SJ, Haas RH (2012) A seven-day study of the pharmacokinetics of intravenous levetiracetam in neonates: marked changes in pharmacokinetics occur during the first week of life. Pediatr Research 72:43–49CrossRef
11.
go back to reference Glass HC, Kan J, Bonifacio SL, Ferriero DM (2012) Neonatal seizures: treatment practices among term and preterm infants. Pediatr Neurol 46:111–115PubMedCrossRef Glass HC, Kan J, Bonifacio SL, Ferriero DM (2012) Neonatal seizures: treatment practices among term and preterm infants. Pediatr Neurol 46:111–115PubMedCrossRef
12.
go back to reference Nahat MC, Masuoka T, Edwards RC (1988) Developmental aspects of phenobarbital dosage requirements in newborn infants with seizures. J Perinatol 8:318–320 Nahat MC, Masuoka T, Edwards RC (1988) Developmental aspects of phenobarbital dosage requirements in newborn infants with seizures. J Perinatol 8:318–320
13.
go back to reference Gherpelli JL, Cruz AM, Tsanaclis LM, Costa HP, Garcia TG, Segre CA, Franca AS (1983) Phenobarbital in newborns with neonatal seizures. A study of plasma levels after intravenous administration. Brain Dev 15:258–262CrossRef Gherpelli JL, Cruz AM, Tsanaclis LM, Costa HP, Garcia TG, Segre CA, Franca AS (1983) Phenobarbital in newborns with neonatal seizures. A study of plasma levels after intravenous administration. Brain Dev 15:258–262CrossRef
14.
go back to reference Kearns KL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE (2003) Developmental pharmacology, drug disposition action, and therapy in infants and children. N Eng J Med 349:1157–1167CrossRef Kearns KL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE (2003) Developmental pharmacology, drug disposition action, and therapy in infants and children. N Eng J Med 349:1157–1167CrossRef
15.
go back to reference Pitlick W, Painter M, Pippenger C (1978) Phenobarbital pharmacokinetics in neonates. Clin Pharmacol Ther 23:346–349PubMed Pitlick W, Painter M, Pippenger C (1978) Phenobarbital pharmacokinetics in neonates. Clin Pharmacol Ther 23:346–349PubMed
16.
go back to reference Gilman ME, Toback JW, Gal P, Erkan NV (1983) Individualizing phenobarbital dosing in neonates. Clin Pharmacol 2:258–262 Gilman ME, Toback JW, Gal P, Erkan NV (1983) Individualizing phenobarbital dosing in neonates. Clin Pharmacol 2:258–262
17.
go back to reference Touw DJ, Graafland O, Cranendonk A, Vermeulen RJ, Weissenbruch MM (2000) Clinical pharmacokinetics of phenobarbital in neonates. Eur J Pharm Sci 12:111–116PubMedCrossRef Touw DJ, Graafland O, Cranendonk A, Vermeulen RJ, Weissenbruch MM (2000) Clinical pharmacokinetics of phenobarbital in neonates. Eur J Pharm Sci 12:111–116PubMedCrossRef
Metadata
Title
Can we safely administer the recommended dose of phenobarbital in very low birth weight infants?
Authors
Osman Oztekin
Salih Kalay
Gonul Tezel
Mustafa Akcakus
Nihal Oygur
Publication date
01-08-2013
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 8/2013
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-013-2094-8

Other articles of this Issue 8/2013

Child's Nervous System 8/2013 Go to the issue